Clinical Trial: BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Prospective, Multi-center, Randomized, Non-blind Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Sulbactam/Ampicillin in the Treatment of Pulmonary Abscess

Brief Summary: The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.

Detailed Summary:
Sponsor: Bayer

Current Primary Outcome: Adverse events occuring after first application of study medication up to the test of cure visit for non-serious adverse events [ Time Frame: Up to 30 days after end of treatment with study medication for serious adverse events ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Clinical Response [ Time Frame: Regulary doing i.v. treatment ]

Original Secondary Outcome: Same as current

Information By: Bayer

Dates:
Date Received: January 8, 2010
Date Started: February 2001
Date Completion:
Last Updated: January 8, 2010
Last Verified: January 2010